COVID-19 MEASURES AND SAFETY PRECAUTIONS (click here).

Who should attend:

• Cardiovascular specialists
• Internists
• Allied health professionals
• Heart failure care teams
• Cardiovascular Trainees, Residents and Fellows
• Basic scientist interested in CV disease
• Primary care providers

Now Open: Call for Abstracts

https://UOttawaheart-apply.smapply.io/prog/toronto-ottawa_heart_summit_call_for_abstracts

Overall Program Learning Objectives

At the end of the program, participants will be able to:

• Elicit and accurately synthesize relevant research data for the purpose of diagnosing and managing patients with complex cardiovascular disease (Scholar, Medical Expert)
• Demonstrate improved understanding of best practice clinical scenarios for patients with multiple co-morbidities and CV disease (Professional, Health Advocate)
• Seek appropriate consultation from others as required, recognizing the limits of their own clinical expertise (Collaborator, Communicator)
• Contribute to the dissemination, application and translation of new knowledge and practices to peers and other professionals (Professional, Manager)

Objectives

Upon completion of this program participants should be able to:

• Recognize current and emerging advancements in CV Risk Prediction
• Demonstrate improved understanding of cardiovascular health through exercise
• Recognize the Long-term Cardiovascular Consequences of COVID-19
• Choose appropriate cardiac imaging in the diagnosis and management of cardiovascular involvement caused by as a sequalae of COVID infection or vaccination
• Select the appropriate antithrombotic treatment for patients with Atrial fibrillation
• Identify best practices for the management of patients with atrial fibrillation
• Illustrate the current recommendations of the Canadian Cardiovascular Society Guidelines for Rate and Rhythm Control Options for atrial Fibrillation
• Determine a practical approach to current and emerging evidence in the diagnosis and management of spontaneous coronary artery dissection
• Outline a practical approach to current and emerging evidence in the diagnosis and management of MI with non-obstructive coronary arteries
• Delineate Strategies for Disease in Women, Improving Risk Stratification, Diagnosis, and Management from a Gender Perspective
• Recognize Presentation and Management of Acute Cardiovascular Complications in Pregnancy
• Summarize current and upcoming advanced treatment strategies in Heart Failure with preserved ejection fraction
• Identify a practical approach to better manage and improve outcomes in patients with heart failure and reduced ejection fraction
• Select the current and emerging devices and remote monitoring platforms that are available to aid in the diagnosis and management of heart failure
• Explain the Long-Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients with Heart Failure
• Examine efficacy of cardiac myosin inhibitor mavacamten, to reduce the need for invasive septal reduction therapies in patients with advanced hypertrophic obstructive cardiomyopathy
• Learn the rationale, methods and results of a large trial on perioperative management of blood pressure and antihypertensive medications
• Recognize the balance, maximizing your gain and minimizing loss when using an SLGT 2 inhibitor
• Discuss new insights into the management of a complex Cardiomyopathy case
• Discuss new insights into the management of patients with coronary artery disease
• Choose medical management of diabetes based on the current guidelines
• Identify LDL lowering targets in patients with cardiovascular disease with and utilization of non statin interventions
• Recognize and understanding the burden of obesity and the cardiovascular impact with the utilization of novel therapies for weight reduction
• Explain the anatomy and disease process that affects the Aortic, Mitral and Tricuspid valve
• Determine best treatment options for patients with Aortic, Mitral and Tricuspid valve disease
• Recognize the limitations and cautions to proceeding with a valvular transcatheter intervention
• Recognize the importance and effect of frailty on patients with cardiovascular disease
• Determine how imaging in cardio oncology can aid in the early diagnosis and identification and follow up in patients receiving chemotherapy whom are at risk of ventricular dysfunction
• Describe the emerging therapies in the management of Diabetic Kidney Disease, benefits , indications and limitations